Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK372475 in Major Depressive Disorder
NCT00448058Phase 2Completed
- Sponsor
- GSK
- Start
- Apr 2007
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 2 trial of NS2359 in major depressive disorder (MDD), sponsored by GSK. Started Apr 2007; status: completed.
02
Drugs
NS2359
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00448058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00448058.